S&P 500   0.67 (+1.82%)
DOW   0.67 (+1.82%)
QQQ   265.19 (-1.89%)
AAPL   452.04 (+3.32%)
MSFT   209.19 (+2.86%)
FB   259.89 (+1.47%)
GOOGL   1,507.24 (+1.80%)
AMZN   3,162.24 (+2.65%)
NVDA   457.61 (+5.44%)
CGC   17.25 (+1.77%)
BABA   255.19 (+2.73%)
TSLA   1,554.76 (+13.12%)
GE   6.72 (-0.15%)
MU   48.48 (+1.51%)
AMD   82.61 (+7.45%)
T   30.18 (-0.07%)
F   7.11 (-1.66%)
ACB   9.80 (-2.20%)
GILD   68.84 (+1.09%)
NFLX   475.47 (+1.83%)
DIS   131.79 (+1.00%)
BAC   26.73 (-0.71%)
BA   175.44 (-2.60%)
S&P 500   0.67 (+1.82%)
DOW   0.67 (+1.82%)
QQQ   265.19 (-1.89%)
AAPL   452.04 (+3.32%)
MSFT   209.19 (+2.86%)
FB   259.89 (+1.47%)
GOOGL   1,507.24 (+1.80%)
AMZN   3,162.24 (+2.65%)
NVDA   457.61 (+5.44%)
CGC   17.25 (+1.77%)
BABA   255.19 (+2.73%)
TSLA   1,554.76 (+13.12%)
GE   6.72 (-0.15%)
MU   48.48 (+1.51%)
AMD   82.61 (+7.45%)
T   30.18 (-0.07%)
F   7.11 (-1.66%)
ACB   9.80 (-2.20%)
GILD   68.84 (+1.09%)
NFLX   475.47 (+1.83%)
DIS   131.79 (+1.00%)
BAC   26.73 (-0.71%)
BA   175.44 (-2.60%)
S&P 500   0.67 (+1.82%)
DOW   0.67 (+1.82%)
QQQ   265.19 (-1.89%)
AAPL   452.04 (+3.32%)
MSFT   209.19 (+2.86%)
FB   259.89 (+1.47%)
GOOGL   1,507.24 (+1.80%)
AMZN   3,162.24 (+2.65%)
NVDA   457.61 (+5.44%)
CGC   17.25 (+1.77%)
BABA   255.19 (+2.73%)
TSLA   1,554.76 (+13.12%)
GE   6.72 (-0.15%)
MU   48.48 (+1.51%)
AMD   82.61 (+7.45%)
T   30.18 (-0.07%)
F   7.11 (-1.66%)
ACB   9.80 (-2.20%)
GILD   68.84 (+1.09%)
NFLX   475.47 (+1.83%)
DIS   131.79 (+1.00%)
BAC   26.73 (-0.71%)
BA   175.44 (-2.60%)
S&P 500   0.67 (+1.82%)
DOW   0.67 (+1.82%)
QQQ   265.19 (-1.89%)
AAPL   452.04 (+3.32%)
MSFT   209.19 (+2.86%)
FB   259.89 (+1.47%)
GOOGL   1,507.24 (+1.80%)
AMZN   3,162.24 (+2.65%)
NVDA   457.61 (+5.44%)
CGC   17.25 (+1.77%)
BABA   255.19 (+2.73%)
TSLA   1,554.76 (+13.12%)
GE   6.72 (-0.15%)
MU   48.48 (+1.51%)
AMD   82.61 (+7.45%)
T   30.18 (-0.07%)
F   7.11 (-1.66%)
ACB   9.80 (-2.20%)
GILD   68.84 (+1.09%)
NFLX   475.47 (+1.83%)
DIS   131.79 (+1.00%)
BAC   26.73 (-0.71%)
BA   175.44 (-2.60%)
Log in

LON:VCTVictrex Share Price, Forecast & News

GBX 1,958
+48.00 (+2.51 %)
(As of 08/12/2020 04:00 PM ET)
Add
Compare
Today's Range
1,921
Now: GBX 1,958
1,976
50-Day Range
1,830
MA: GBX 1,932.86
2,064
52-Week Range
1,645
Now: GBX 1,958
2,574
Volume183,456 shs
Average Volume274,177 shs
Market Capitalization£1.70 billion
P/E Ratio18.99
Dividend Yield3.02%
BetaN/A
Victrex plc, through its subsidiaries, manufactures and sells polymers worldwide. The company offers VICTREX PEEK polymer materials; and biomaterial solutions for use in spine, ortho, dental, trauma, knee, cardiovascular, and orthopedic applications. It also offers specialist solutions for medical device manufacturers. It serves automotive, aerospace, energy, manufacturing and engineering, electronics, and medical markets. The company was incorporated in 1993 and is headquartered in Thornton Cleveleys, the United Kingdom.
Read More
Victrex logo

Beat the Market (BTM) Rank

Analyst Opinion: 1.9Community Rank: 2.4Dividend Strength: 1.7Insider Behavior: 3.0Valuation: 0.6 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.92 out of 5 stars


Industry, Sector and Symbol

Industry Specialty Chemicals
Sub-IndustryN/A
CUSIPN/A
CIKN/A
Phone+44-1253-897700

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales£299.80 million
Cash FlowGBX 64.05 per share
Book ValueGBX 542.10 per share

Profitability

Miscellaneous

Employees921
Market Cap£1.70 billion
Next Earnings DateN/A
OptionableNot Optionable
GBX 1,958
+48.00 (+2.51 %)
(As of 08/12/2020 04:00 PM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive VCT News and Ratings via Email

Sign-up to receive the latest news and ratings for VCT and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Victrex (LON:VCT) Frequently Asked Questions

How has Victrex's stock price been impacted by COVID-19?

Victrex's stock was trading at GBX 1,952 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization. Since then, VCT shares have increased by 0.3% and is now trading at GBX 1,958.
View which stocks have been most impacted by COVID-19
.

Do Wall Street analysts recommend investors buy shares of Victrex?

11 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Victrex in the last year. There are currently 4 sell ratings, 5 hold ratings and 2 buy ratings for the stock, resulting in a consensus recommendation of "Hold."
View analyst ratings for Victrex
.

How were Victrex's earnings last quarter?

Victrex plc (LON:VCT) posted its quarterly earnings data on Monday, May, 11th. The company reported $47.60 earnings per share (EPS) for the quarter.
View Victrex's earnings history
.

How often does Victrex pay dividends? What is the dividend yield for Victrex?

Victrex announced a dividend on Thursday, December 5th. Investors of record on Thursday, January 30th will be paid a dividend of GBX 46.14 per share on Friday, February 21st. This represents a dividend yield of 1.98%. The ex-dividend date is Thursday, January 30th. This is a boost from Victrex's previous dividend of GBX 13.42. The official announcement can be viewed at this link.
View Victrex's dividend history
.

What price target have analysts set for VCT?

11 analysts have issued 1-year price targets for Victrex's stock. Their forecasts range from GBX 1,650 to GBX 2,400. On average, they expect Victrex's stock price to reach GBX 1,966.82 in the next year. This suggests a possible upside of 0.5% from the stock's current price.
View analysts' price targets for Victrex
.

Has Victrex been receiving favorable news coverage?

Press coverage about VCT stock has been trending very negative this week, InfoTrie Sentiment Analysis reports. InfoTrie scores the sentiment of news coverage by reviewing more than six thousand blog and news sources in real time. The firm ranks coverage of companies on a scale of -5 to 5, with scores closest to five being the most favorable. Victrex earned a news impact score of -3.9 on InfoTrie's scale. They also gave press coverage about the company a news buzz of 10.0 out of 10, indicating that recent news coverage is extremely likely to have an effect on the stock's share price in the near future.
View the latest news about Victrex
.

Who are some of Victrex's key competitors?

What other stocks do shareholders of Victrex own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Victrex investors own include Centamin (CEY), Anglo American (AAL), Renishaw (RSW), Hastings Group (HSTG), Rotork (ROR), Playtech (PTEC), Spirent Communications (SPT), Ashtead Group (AHT), Rio Tinto (RIO) and GlaxoSmithKline (GSK).

Who are Victrex's key executives?

Victrex's management team includes the following people:
  • Mr. Jakob O. Sigurdsson BA, MBA, CEO & Exec. Director (Age 55)
  • Mr. Richard Armitage, Group Fin. Director & Exec. Director (Age 53)
  • Mr. Timothy J. Cooper, Exec. Director of Industrial & Exec. Director
  • Dr. Martin L. Court, Exec. Director of Medical & Exec. Director (Age 57)
  • Mr. Andrew Hanson, Director of Investor Relations & Corp. Communications

What is Victrex's stock symbol?

Victrex trades on the London Stock Exchange (LON) under the ticker symbol "VCT."

How do I buy shares of Victrex?

Shares of VCT and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

What is Victrex's stock price today?

One share of VCT stock can currently be purchased for approximately GBX 1,958.

How big of a company is Victrex?

Victrex has a market capitalization of £1.70 billion and generates £299.80 million in revenue each year. Victrex employs 921 workers across the globe.

What is Victrex's official website?

The official website for Victrex is www.victrexplc.com.

How can I contact Victrex?

Victrex's mailing address is Victrex Technology Centre , Hillhouse International,, THORNTON CLEVELEYS, FY5 4QD, United Kingdom. The company can be reached via phone at +44-1253-897700.

This page was last updated on 8/12/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.